Related Research Articles
James M. Robins is an epidemiologist and biostatistician best known for advancing methods for drawing causal inferences from complex observational studies and randomized trials, particularly those in which the treatment varies with time. He is the 2013 recipient of the Nathan Mantel Award for lifetime achievement in statistics and epidemiology, and a recipient of the 2022 Rousseeuw Prize in Statistics, jointly with Miguel Hernán, Eric Tchetgen-Tchetgen, Andrea Rotnitzky and Thomas Richardson.
In medical research, a dynamic treatment regime (DTR), adaptive intervention, or adaptive treatment strategy is a set of rules for choosing effective treatments for individual patients. Historically, medical research and the practice of medicine tended to rely on an acute care model for the treatment of all medical problems, including chronic illness. Treatment choices made for a particular patient under a dynamic regime are based on that individual's characteristics and history, with the goal of optimizing his or her long-term clinical outcome. A dynamic treatment regime is analogous to a policy in the field of reinforcement learning, and analogous to a controller in control theory. While most work on dynamic treatment regimes has been done in the context of medicine, the same ideas apply to time-varying policies in other fields, such as education, marketing, and economics.
Mary Elizabeth (Betz) Halloran is an American biostatistician who works as a professor of biostatistics, professor of epidemiology, and adjunct professor of applied mathematics at the University of Washington.
Grace Yun Yi is a professor of the University of Western Ontario where she currently holds a Tier I Canada Research Chair in Data Science. She was a professor at the University of Waterloo, Canada, where she holds a University Research Chair in Statistical and Actuarial Science. Her research concerns event history analysis with missing data and its applications in medicine, engineering, and social science.
Francesca Dominici is a Harvard Professor who develops methodology in causal inference and data science and led research projects that combine big data with health policy and climate change. She is a professor of biostatistics, co-director of the Harvard Data Science Initiative, and a former senior associate dean for research in the Harvard T.H. Chan School of Public Health.
Rongwei (Rochelle) F. Fu is a biostatistician who uses meta-analysis to understand disease incidence, detection, and treatment. She is a professor of biostatistics, medical informatics and clinical epidemiology at the Oregon Health & Science University (OHSU), and the director of biostatistics education at OHSU. She has also worked as lead biostatistician for the OHSU Center for Policy and Research in Emergency Medicine (CPR-EM), at the Pacific Northwest Evidence-based Practice Center (EPC), and at the OHSU Research Center for Gender-Based Medicine.
Motomi (Tomi) Mori is a Japanese biostatistician. Formerly the Walter & Clora Brownfield Professor of Cancer Biostatistics at the Knight Cancer Institute of Oregon Health & Science University (OHSU), she was named endowed professor and chair of biostatistics at St. Jude Children's Research Hospital in 2020. She is the chair of the Caucus for Women in Statistics for 2021.
Bhramar Mukherjee is an Indian-American biostatistician, data scientist, professor and researcher. She is the John D. Kalbfleisch Distinguished University Professor of Biostatistics, Siobán D. Harlow Collegiate Professor of Public Health and the Chair of Department of Biostatistics, a professor of epidemiology and global public health at the University of Michigan. She serves as the associate director for Quantitative Data Sciences at University of Michigan Rogel Cancer Center. Mukherjee holds a Senior Honorary Visiting Fellow position at the Biostatistics Unit of the Medical Research Council, working on the theme of population health at the University of Cambridge, UK. She has served as the past Chair for Committee of Presidents of Statistical Societies (COPSS) for a three-year term 2019-2021.
Nicola G. "Nicky" Best is a statistician known for her work on the deviance information criterion in Bayesian inference[B][E] and as a developer of Bayesian inference using Gibbs sampling.[A][D] She is a former professor of biostatistics and epidemiology at Imperial College London and is currently a biostatistician for GlaxoSmithKline.
Babette Anne Brumback is an American biostatistician known for her work on causal inference. She is a professor of biostatistics at the University of Florida.
Sherri Rose is an American biostatistician. She is an associate professor of health care policy at Stanford University, and once worked at Harvard University. A fellow of the American Statistical Association, she has served as co-editor of Biostatistics since 2019 and Chair of the American Statistical Association’s Biometrics Section. Her research focuses on statistical machine learning for health care policy.
Rebecca Allana Hubbard is an American biostatistician whose research interests include observational studies and the use of electronic health record data in public health analysis and decision-making, accounting for the errors in this type of data. She is a professor of biostatistics in the Perelman School of Medicine at the University of Pennsylvania.
Donna Spiegelman is a biostatistician and epidemiologist who works at the interface between the two fields as a methodologist, applying statistical solutions to address potential biases in epidemiologic studies.
Rui Song is a Chinese-American statistician. Her research interests include machine learning, causal inference, and independence screening for variable selection, with applications to precision medicine and economics. She works for Amazon as a senior principal scientist.
Emma Katherine Tara Benn is an American biostatistician whose research includes causal inference in health disparities as a way to help find targets for intervention against these disparities. She works at the Icahn School of Medicine at Mount Sinai, where she is an associate professor in the Department of Population Health Science, affiliated with the Center for Biostatistics. She is also associate dean of faculty well-being and development, and the founding director of the Center for Scientific Diversity at the Icahn School.
Andrea Gloria Rotnitzky is an Argentine biostatistician whose research involves causal inference on the effects of medical interventions in the face of missing data. She is Prentice Endowed Professor of Biostatistics in the University of Washington School of Public Health.
Robert L. Strawderman is an academic biostatistician and researcher who holds the Donald M. Foster, MD Distinguished Professorship in Biostatistics at the University of Rochester. He has served as chair of the Department of Biostatistics and Computational Biology since 2012. Strawderman's principal research interests include semiparametric methods for missing and censored data and statistical learning methods for risk and outcome prediction. Contributions in numerous other areas include inference and variable selection in the areas of dynamic treatment regimes and causal inference in mediation analysis and for recurrent events.
Layla Mosama Parast Bartroff is an American biostatistician whose research involves surrogate markers, predictive modelling, survival analysis, causal inference, and health care quality. Formerly a senior statistician and co-director of the Center for Causal Inference at the RAND Corporation, she is an associate professor of statistics and data sciences at the University of Texas at Austin. She is also a frequent newspaper and news magazine editorial writer on issues related to public health, supported as a Public Voices Fellow of The OpEd Project.
Lu Wang is a Chinese-American biostatistician whose research topics have included causal inference, dynamic decision-making for medical treatments, missing data, and environmental health. She has also studied the correlation between mercury from seafood and autoimmune disease, and the benefits of providing improved transportation services for healthcare, as a member of the Michigan Institute for Healthcare Policy & Innovation. She is a professor of biostatistics and associate chair for research in biostatistics in the University of Michigan School of Public Health.
References
- 1 2 3 4 Erica Moodie, CRM-SSC Prize in Statistics 2020, Statistical Society of Canada, retrieved 2020-07-02
- 1 2 3 Curriculum vitae (PDF), 31 March 2020, retrieved 2020-07-02
- ↑ An, Hyonggin (September 2015), "Review of Statistical Methods for Dynamic Treatment Regimes", Journal of Agricultural, Biological, and Environmental Statistics, 20 (3): 433–434, doi:10.1007/s13253-015-0204-7, JSTOR 26451843, S2CID 123717906
- 1 2 Moodie, Ric, Something about Ric Moodie , retrieved 2020-07-02
- ↑ Sisters Erica and Zoe Moodie use biostatistics to improve the world of medicine, University of Winnipeg, 23 November 2018, retrieved 2020-07-02
